These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Simulated post-exposure rabies vaccination: comments on article by Madhusudana et al. Wilde H; Khawplod P; Hemachudha T Int J Infect Dis; 2004 Nov; 8(6):374-5; author reply 376. PubMed ID: 15494259 [No Abstract] [Full Text] [Related]
3. A pilot study on intradermal vaccination of Japanese rabies vaccine for pre-exposure immunization. Shiota S; Khawplod P; Ahmed K; Mifune K; Nishizono A Vaccine; 2008 Nov; 26(50):6441-4. PubMed ID: 18804510 [TBL] [Abstract][Full Text] [Related]
4. Duration of immunity: an anamnestic response 14 years after rabies vaccination with purified chick embryo cell rabies vaccine. Malerczyk C; Briggs DJ; Dreesen DW; Banzhoff A J Travel Med; 2007; 14(1):63-4. PubMed ID: 17241256 [No Abstract] [Full Text] [Related]
5. Antigen content versus volume of rabies vaccines administered intradermally. Dodet B Biologicals; 2011 Nov; 39(6):444-5. PubMed ID: 22000166 [No Abstract] [Full Text] [Related]
7. Simulated post-exposure rabies vaccination with purified chick embryo cell vaccine using a modified Thai Red Cross regimen. Madhusudana SN; Sanjay TV; Mahendra BJ; Suja MS Int J Infect Dis; 2004 May; 8(3):175-9. PubMed ID: 15109593 [TBL] [Abstract][Full Text] [Related]
8. A three-year clinical study on immunogenicity, safety, and booster response of purified chick embryo cell rabies vaccine administered intramuscularly or intradermally to 12- to 18-month-old Thai children, concomitantly with Japanese encephalitis vaccine. Pengsaa K; Limkittikul K; Sabchareon A; Ariyasriwatana C; Chanthavanich P; Attanath P; Malerczyk C Pediatr Infect Dis J; 2009 Apr; 28(4):335-7. PubMed ID: 19333080 [TBL] [Abstract][Full Text] [Related]
9. Comparative evaluation of immunogenicity, reactogenecity and safety of purified chick embryo cell rabies vaccine and neural tissue rabies vaccine. Deshpande AK; Londhe VA; Akarte S; Briggs D J Assoc Physicians India; 2003 Jul; 51():655-8. PubMed ID: 14621031 [TBL] [Abstract][Full Text] [Related]
10. Boosting effect of purified chick embryo cell rabies vaccine using the intradermal route in persons previously immunized by the intramuscular route or vice versa. Sudarshan MK; Madhusudana SN; Mahendra BJ; Narayana DH; Giri MS; Muhamuda K; Ravish HS; Venkatesh GM Natl Med J India; 2006; 19(4):192-4. PubMed ID: 17100105 [TBL] [Abstract][Full Text] [Related]
11. Antibody response of patients after postexposure rabies vaccination with small intradermal doses of purified chick embryo cell vaccine or purified Vero cell rabies vaccine. Briggs DJ; Banzhoff A; Nicolay U; Sirikwin S; Dumavibhat B; Tongswas S; Wasi C Bull World Health Organ; 2000; 78(5):693-8. PubMed ID: 10859864 [TBL] [Abstract][Full Text] [Related]
12. One or three intradermal injections within one week for rabies pre-exposure immunization. Khawplod P; Wilde H; Sriaroon C; Chomchey P; Kamolthum T; Sitprija V Dev Biol (Basel); 2008; 131():393-401. PubMed ID: 18634501 [TBL] [Abstract][Full Text] [Related]
13. Immunogenicity of purified chick embryo cell anti-rabies vaccine in post-exposure treatment of animal bite cases. Bhardwaj M; Bhattacharya D; Chhabra M; Ichhpujani RL J Commun Dis; 2002 Mar; 34(1):40-2. PubMed ID: 12718340 [TBL] [Abstract][Full Text] [Related]
14. Pre-exposure immunization against rabies using Japanese rabies vaccine following the WHO recommended schedule. Yanagisawa N; Takayama N; Nakayama E; Mannen K; Suganuma A J Infect Chemother; 2010 Feb; 16(1):38-41. PubMed ID: 20063031 [TBL] [Abstract][Full Text] [Related]
15. Intradermal pre-exposure rabies immunisation in New Zealand. Shaw MM; Leggat PA; Williams ML Travel Med Infect Dis; 2006 Jan; 4(1):29-33. PubMed ID: 16887722 [TBL] [Abstract][Full Text] [Related]
16. Revision of the Thai Red Cross intradermal rabies post-exposure regimen by eliminating the 90-day booster injection. Khawplod P; Wilde H; Sirikwin S; Benjawongkulchai M; Limusanno S; Jaijaroensab W; Chiraguna N; Supich C; Wangroongsarb Y; Sitprija V Vaccine; 2006 Apr; 24(16):3084-6. PubMed ID: 16494972 [TBL] [Abstract][Full Text] [Related]
17. Three-year experience with 4-site intradermal booster vaccination with rabies vaccine for postexposure prophylaxis. Tantawichien T; Tantawichien T; Supit C; Khawplod P; Sitprija V Clin Infect Dis; 2001 Dec; 33(12):2085-7. PubMed ID: 11712097 [TBL] [Abstract][Full Text] [Related]
18. Rabies post-exposure prophylaxis vaccination with purified chick embryo cell vaccine (PCECV) and purified Vero cell rabies vaccine (PVRV) in a four-site intradermal schedule (4-0-2-0-1-1): an immunogenic, cost-effective and practical regimen. Ambrozaitis A; Laiskonis A; Balciuniene L; Banzhoff A; Malerczyk C Vaccine; 2006 May; 24(19):4116-21. PubMed ID: 16545510 [TBL] [Abstract][Full Text] [Related]
19. Rabies antibody seroprotection rates among travelers in Nepal: "rabies seroprotection in travelers". Ranney M; Partridge R; Jay GD; Rozzoli DE; Pandey P J Travel Med; 2006; 13(6):329-33. PubMed ID: 17107424 [TBL] [Abstract][Full Text] [Related]
20. Antibody response to a single intradermal booster dose of rabies human diploid cell vaccine. Dreesen DW; Kemp DT; Brown J; Brown WJ J Am Vet Med Assoc; 1983 Dec; 183(12):1468-70. PubMed ID: 6654729 [No Abstract] [Full Text] [Related] [Next] [New Search]